Virax Biolabs Group Ltd. (VRAX)
Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
1. 62
-0.03
-1.8061%
Pre Market
$
+0.08 +4.9253% 1. 70
348.99K Market Cap
- P/E Ratio
- Div Yield
44,169 Volume
0 Eps
$ 1.65
Previous Close Want to track VRAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Virax Biolabs Group Ltd. (VRAX) Statistics
Valuation metrics
Market Cap 348.99K
Enterprise value -5.68M
Trailing P/E (ttm) -0.08
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 24.87
Price/Book (mrq) 0.1
Enterprise Value/Revenue -404.5
Enterprise Value/EBITDA 0.72
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 460.74K
Average volume (90 days) 825.73K
Price summary
52-Week low 1.55
52-Week high 21.75
Beta -
50-Day moving average 2.52
200-Day moving average 1.42
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 26 Jun 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -524.73%
Operating margin -640.38%
Operational effectiveness
Return on assets -0.88%
Return on equity -1.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -18.52
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 16.39
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 9.97%
Book value per share (mrq) 18.45
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
